RUNX1 and acute lymphoblastic leukemia: In our second cohort of B-ALL patients analysed by SNP6.0 array [31], large deletions of 6q were seen in 4/17 (24%) cases with ETV6::RUNX1-positive ALL compared to 15/302 (5%) overall.